180 related articles for article (PubMed ID: 17090088)
1. Squalenoyl nanomedicines as potential therapeutics.
Couvreur P; Stella B; Reddy LH; Hillaireau H; Dubernet C; Desmaële D; Lepêtre-Mouelhi S; Rocco F; Dereuddre-Bosquet N; Clayette P; Rosilio V; Marsaud V; Renoir JM; Cattel L
Nano Lett; 2006 Nov; 6(11):2544-8. PubMed ID: 17090088
[TBL] [Abstract][Full Text] [Related]
2. Anticancer efficacy of squalenoyl gemcitabine nanomedicine on 60 human tumor cell panel and on experimental tumor.
Reddy LH; Renoir JM; Marsaud V; Lepetre-Mouelhi S; Desmaële D; Couvreur P
Mol Pharm; 2009; 6(5):1526-35. PubMed ID: 19634915
[TBL] [Abstract][Full Text] [Related]
3. Squalenoyl nucleoside monophosphate nanoassemblies: new prodrug strategy for the delivery of nucleotide analogues.
Caron J; Reddy LH; Lepêtre-Mouelhi S; Wack S; Clayette P; Rogez-Kreuz C; Yousfi R; Couvreur P; Desmaële D
Bioorg Med Chem Lett; 2010 May; 20(9):2761-4. PubMed ID: 20363623
[TBL] [Abstract][Full Text] [Related]
4. ["Squalenoylation": a new approach to the design of anticancer and antiviral nanomedicines].
Couvreur P
Bull Acad Natl Med; 2009 Mar; 193(3):663-73; discussion 673-4. PubMed ID: 19883017
[TBL] [Abstract][Full Text] [Related]
5. Preclinical toxicology (subacute and acute) and efficacy of a new squalenoyl gemcitabine anticancer nanomedicine.
Reddy LH; Marque PE; Dubernet C; Mouelhi SL; Desmaële D; Couvreur P
J Pharmacol Exp Ther; 2008 May; 325(2):484-90. PubMed ID: 18258784
[TBL] [Abstract][Full Text] [Related]
6. A new nanomedicine of gemcitabine displays enhanced anticancer activity in sensitive and resistant leukemia types.
Reddy LH; Dubernet C; Mouelhi SL; Marque PE; Desmaele D; Couvreur P
J Control Release; 2007 Dec; 124(1-2):20-7. PubMed ID: 17878060
[TBL] [Abstract][Full Text] [Related]
7. Anti-HIV efficacy and biodistribution of nucleoside reverse transcriptase inhibitors delivered as squalenoylated prodrug nanoassemblies.
Hillaireau H; Dereuddre-Bosquet N; Skanji R; Bekkara-Aounallah F; Caron J; Lepêtre S; Argote S; Bauduin L; Yousfi R; Rogez-Kreuz C; Desmaële D; Rousseau B; Gref R; Andrieux K; Clayette P; Couvreur P
Biomaterials; 2013 Jul; 34(20):4831-8. PubMed ID: 23562054
[TBL] [Abstract][Full Text] [Related]
8. Self-assembled squalenoyl-cytarabine nanostructures as a potent nanomedicine for treatment of leukemic diseases.
Cosco D; Rocco F; Ceruti M; Vono M; Fresta M; Paolino D
Int J Nanomedicine; 2012; 7():2535-46. PubMed ID: 22679366
[TBL] [Abstract][Full Text] [Related]
9. Squalenoyl-gemcitabine/edelfosine nanoassemblies: Anticancer activity in pediatric cancer cells and pharmacokinetic profile in mice.
Rodríguez-Nogales C; Mura S; Couvreur P; Blanco-Prieto MJ
Int J Pharm; 2020 May; 582():119345. PubMed ID: 32311470
[TBL] [Abstract][Full Text] [Related]
10. A unique multidrug nanomedicine made of squalenoyl-gemcitabine and alkyl-lysophospholipid edelfosine.
Rodríguez-Nogales C; Sebastián V; Irusta S; Desmaële D; Couvreur P; Blanco-Prieto MJ
Eur J Pharm Biopharm; 2019 Nov; 144():165-173. PubMed ID: 31546021
[TBL] [Abstract][Full Text] [Related]
11. Decoration of Squalenoyl-Gemcitabine Nanoparticles with Squalenyl-Hydroxybisphosphonate for the Treatment of Bone Tumors.
Rodríguez-Nogales C; Desmaële D; Sebastián V; Couvreur P; Blanco-Prieto MJ
ChemMedChem; 2021 Dec; 16(24):3730-3738. PubMed ID: 34581019
[TBL] [Abstract][Full Text] [Related]
12. Novel nanoassemblies composed of squalenoyl-paclitaxel derivatives: synthesis, characterization, and biological evaluation.
Dosio F; Reddy LH; Ferrero A; Stella B; Cattel L; Couvreur P
Bioconjug Chem; 2010 Jul; 21(7):1349-61. PubMed ID: 20597546
[TBL] [Abstract][Full Text] [Related]
13. Squalenoyl nanomedicine of gemcitabine is more potent after oral administration in leukemia-bearing rats: study of mechanisms.
Reddy LH; Ferreira H; Dubernet C; Mouelhi SL; Desmaele D; Rousseau B; Couvreur P
Anticancer Drugs; 2008 Nov; 19(10):999-1006. PubMed ID: 18827565
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and potent anti-leukemic activity of novel 5'-deoxycarbocyclic C-nucleoside phosphonic acids.
Kim E; Hong JH
Nucleosides Nucleotides Nucleic Acids; 2015; 34(11):737-52. PubMed ID: 26398671
[TBL] [Abstract][Full Text] [Related]
15. Discovery of new hexagonal supramolecular nanostructures formed by squalenoylation of an anticancer nucleoside analogue.
Couvreur P; Reddy LH; Mangenot S; Poupaert JH; Desmaële D; Lepêtre-Mouelhi S; Pili B; Bourgaux C; Amenitsch H; Ollivon M
Small; 2008 Feb; 4(2):247-53. PubMed ID: 18247384
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic modalities of squalenoyl nanocomposites in colon cancer: an ongoing search for improved efficacy.
Maksimenko A; Alami M; Zouhiri F; Brion JD; Pruvost A; Mougin J; Hamze A; Boissenot T; Provot O; Desmaële D; Couvreur P
ACS Nano; 2014 Mar; 8(3):2018-32. PubMed ID: 24555414
[TBL] [Abstract][Full Text] [Related]
17. Recent developments to improve the efficacy of cytotoxic nucleoside analogues.
Jordheim LP; Galmarini CM; Dumontet C
Recent Pat Anticancer Drug Discov; 2006 Jun; 1(2):163-70. PubMed ID: 18221034
[TBL] [Abstract][Full Text] [Related]
18. Freeze-drying of squalenoylated nucleoside analogue nanoparticles.
Bildstein L; Hillaireau H; Desmaële D; Lepêtre-Mouelhi S; Dubernet C; Couvreur P
Int J Pharm; 2009 Nov; 381(2):140-5. PubMed ID: 19782881
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and anticancer activity of novel C6-piperazine substituted purine steroid-nucleosides analogues.
Huang LH; Xu HD; Yang ZY; Zheng YF; Liu HM
Steroids; 2014 Apr; 82():1-6. PubMed ID: 24378780
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of new nucleoside analogues comprising a geminal difluorocyclopropane moiety as potential antiviral/antitumor agents.
Qiu YL; Zemlicka J
Nucleosides Nucleotides; 1999 Oct; 18(10):2285-300. PubMed ID: 10616730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
